CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 71 to 82.

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

The CRISPR-Cas9 gene-editing tool is as much in the spotlight as it is under scrutiny. Researchers are eager to make genetic modifications to DNA across ...